ATLASFulcrum Therapeutics (FULC) earnings date: Nov 4, 2026
Fulcrum Therapeutics (FULC) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 4, 2026. Analysts expect EPS of -$0.10.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on FULC
| Last price | $3.69 (-0.7%) |
|---|---|
| Normal 1-day range (±1σ) | ±2.5% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Fulcrum Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Fulcrum Therapeutics reports on Nov 4, 2026. One email the day before, with ATLAS’s read on Fulcrum Therapeutics. You can switch it off at any time.
Alert me before FULC reportsFree to start. Creating an account takes under a minute.
Notify me when Fulcrum Therapeutics reports
Track FULC free Add Fulcrum Therapeutics to a free ATLAS watchlist and see its next report date in one place.
FULC earnings at a glance
| Next report (confirmed) | Wed, Nov 4, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.10 |
| Last report | Jul 30, 2026 · In line |
| Beat rate (last 5 reports) | 2 of 5 (40%) |
| Average EPS surprise | +6.6% |
| Average move around a report | ±7.7% (last 5) |
| Sector | Healthcare · Biotechnology |
Fulcrum Therapeutics earnings history: last 5 reports
Fulcrum Therapeutics last reported on Jul 30, 2026: EPS of -$0.22 against an estimate of -$0.22 (0.0% surprise), in line with the estimate.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Jul 30, 2026 | -$0.22 | -$0.22 | 0.0% | In line | -1.1% |
| Apr 27, 2026 | -$0.30 | -$0.25 | +16.7% | Beat | -5.1% |
| Feb 24, 2026 | -$0.30 | -$0.31 | -3.3% | Miss | -17.5% |
| Oct 29, 2025 | -$0.29 | -$0.31 | -6.9% | Miss | -14.0% |
| Sep 21, 2025 | $0.38 | $0.48 | +26.3% | Beat | -0.5% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for FULC
See the fair value, the probability range and the earnings history of Fulcrum Therapeutics on its ATLAS page.
Fulcrum Therapeutics (FULC) stock analysisPlans from €3.99 a month.
Fulcrum Therapeutics earnings: frequently asked questions
When does Fulcrum Therapeutics (FULC) report earnings?
Fulcrum Therapeutics is scheduled to report on Wednesday, November 4, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for FULC?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.10 per share (USD). Estimates can change before the report.
How often does FULC beat earnings estimates?
Of its last 5 reports with a recorded result, Fulcrum Therapeutics beat the EPS estimate 2 times; the average surprise was +6.6%. Past results do not predict the next one.
How much does FULC move around earnings?
Over its last 5 reports the stock moved an average of 7.7% (absolute, from the close before the report day to the close after it), and finished higher 0 of 5 times.
Did Fulcrum Therapeutics beat earnings estimates last quarter?
Fulcrum Therapeutics last reported on Jul 30, 2026: EPS of -$0.22 against an estimate of -$0.22 (0.0% surprise), in line with the estimate.
How much does FULC usually move in a day?
On a normal trading day the ATLAS model puts FULC’s one-day range at about ±2.5%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 4, 2026
Educational information, not investment advice. Disclaimer